• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: ABBOTT GMBH MAGNESIUM

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

ABBOTT GMBH MAGNESIUM Back to Search Results
Model Number 03P6822
Device Problem High Test Results (2457)
Patient Problem No Consequences Or Impact To Patient (2199)
Event Date 03/01/2020
Event Type  malfunction  
Manufacturer Narrative
An evaluation is in process.A follow-up report will be submitted when the evaluation is complete.
 
Event Description
The customer observed falsely elevated magnesium results for two patient samples tested on the architect c4000 analyzer.The following data was provided: sid (b)(6): initial result 6.7, repeat 1.9, 1.9 mg/dl (repeated with sid (b)(6)).Sid (b)(6): initial result 2.7, repeat 1.1, 1.0 mg/dl (repeated with sid (b)(6)).The customer uses normal range 1.6 - 2.6 mg/dl.No impact to patient management was reported.
 
Manufacturer Narrative
A review of tickets determined that there is normal complaint activity for lot 04426un19.Trending review determined no adverse trend for falsely elevated results for the product.Return testing was not completed as returns were not available.Historical performance of reagent lot 04426un19 was evaluated using world wide data from abbottlink.The patient data was analyzed and compared to an established control limit.This evaluation indicated that the patient median result for lot 04426un19 is within the established control limits.Therefore, no unusual reagent lot performance was identified.A review of the manufacturing documentation did not identify any issues associated with the customer's observation.A review of the product labeling concluded that the issue is sufficiently addressed.Based on the investigation, no product deficiency was identified for the architect magnesium reagent, lot 04426un19.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
MAGNESIUM
Type of Device
MAGNESIUM
Manufacturer (Section D)
ABBOTT GMBH
max-planck-ring 2
wiesbaden 65205
GM  65205
MDR Report Key9899357
MDR Text Key189247623
Report Number3002809144-2020-00245
Device Sequence Number1
Product Code JGJ
UDI-Device Identifier00380740161620
UDI-Public00380740161620
Combination Product (y/n)N
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type health professional
Type of Report Initial,Followup
Report Date 04/27/2020
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Expiration Date03/18/2020
Device Model Number03P6822
Device Catalogue Number03P68-22
Device Lot Number04426UN19
Was Device Available for Evaluation? No
Initial Date Manufacturer Received 03/02/2020
Initial Date FDA Received03/30/2020
Supplement Dates Manufacturer Received04/27/2020
Supplement Dates FDA Received04/27/2020
Is This a Reprocessed and Reused Single-Use Device? No
Patient Sequence Number1
Treatment
ARCHITECT C4000 ANALYZER; ARCHITECT C4000 ANALYZER; LN 02P24-40, SN (B)(6) ; LN 02P24-40, SN (B)(6)
-
-